Alembic Pharmaceuticals Limited (NSE:APLLTD)
India · Delayed Price · Currency is INR 763.00
+13.30 (1.77%)
Jun 19, 2026, 3:29 PM IST
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 149.98 billion as of June 18, 2026. Its market cap has decreased by -25.05% in one year.
Market Cap
149.98B
Enterprise Value
162.19B
Revenue
73.45B
Ranking
n/a
PE Ratio
22.23
Stock Price
763.00
Market Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 149.98B, an increase of 1,566.12%. That is a compound annual growth rate of 21.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 149.98B | -9.83% |
| Dec 31, 2025 | 166.32B | -20.64% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 336.71B |
| Wockhardt | 326.79B |
| Piramal Pharma | 211.00B |
| Eris Lifesciences | 200.70B |
| NATCO Pharma | 159.23B |
| Cohance Lifesciences | 155.26B |
| Alivus Life Sciences | 131.37B |
| Strides Pharma Science | 102.39B |